Format

Send to

Choose Destination
Endocr Relat Cancer. 2018 Mar;25(3):R163-R177. doi: 10.1530/ERC-17-0405. Epub 2017 Dec 18.

Genetic testing for indeterminate thyroid cytology: review and meta-analysis.

Author information

1
Department of Surgical OncologyFaculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile.
2
Department of EndocrinologyFaculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
3
GeneproDXSantiago, Chile.
4
Department of Internal MedicinePontificia Universidad Católica de Chile, Santiago, Chile.
5
Department of Clinical LaboratoriesFaculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
6
Department of Surgical OncologyFaculty of Medicine, Pontificia Universidad Católica de Chile , Santiago, Chile hgonzale@med.puc.cl.

Abstract

Thyroid cancer is the most frequent endocrine malignancy, and its incidence is increasing. A current limitation of cytological evaluation of thyroid nodules is that 20-25% are reported as indeterminate. Therefore, an important challenge for clinicians is to determine whether an indeterminate nodule is malignant, and should undergo surgery, or benign, and should be recommended to follow-up. The emergence of precision medicine has offered a valuable solution for this problem, with four tests currently available for the molecular diagnosis of indeterminate cytologies. However, efforts to critically analyze the quality of the accumulated evidence are scarce. This systematic review and meta-analysis is aimed to contribute to a better knowledge about the four available molecular tests, their technical characteristics, clinical performance, and ultimately to help clinicians to make better decisions to provide the best care options possible. For this purpose, we address three critical topics: (i) the proper theoretical accuracy, considering the intended clinical use of the test (rule-in vs rule-out) and the impact on clinical decisions; (ii) the quality of the evidence reported for each test (iii) and how accurate and effective have the tests proved to be after their clinical use. Together with the upcoming evidence, this work provides significant and useful information for healthcare system decision-makers to consider the use of molecular testing as a public health need, avoiding unnecessary surgical risks and costs.

KEYWORDS:

accuracy; indeterminate thyroid cytology; meta-analysis; molecular diagnostics

PMID:
29255094
PMCID:
PMC5799829
DOI:
10.1530/ERC-17-0405
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center